Yasuo Hirayama

Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia

Takuya Matsunaga, Naofumi Takemoto, Tsutomu Sato et al. · Nature Medicine · 2003 · 542 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Hematology +11

Effect of <i>Helicobacter pylori</i> eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura

Kyuhei Kohda, Takashi Kuga, Katsuhisa Kogawa et al. · British Journal of Haematology · 2002 · 148 citations

Thrombopoiesis, Thrombosis, Autoimmune Disease +15

Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies

Mitsutoshi Kurosawa, Masakatsu Yonezumi, Satoshi Hashino et al. · International Journal of Hematology · 2012 · 125 citations

Treatment Outcome, Antifungal Agent, Antifungal Agents +5

Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial

Yasuo Hirayama, Kunihiko Ishitani, Yasushi Sato et al. · International Journal of Clinical Oncology · 2015 · 108 citations

Pain Medicine, Diabetic Neuropathy, Pharmacology +8

Concentrations of Thrombopoietin in Bone Marrow in Normal Subjects and in Patients With Idiopathic Thrombocytopenic Purpura, Aplastic Anemia, and Essential Thrombocythemia Correlate With Its mRNA Expression of Bone Marrow Stromal Cells

Yasuo Hirayama, Sumio Sakamaki, Takuya Matsunaga et al. · Blood · 1998 · 98 citations